» Articles » PMID: 18786988

Pathogenicity and Vaccine Efficacy of Different Clades of Asian H5N1 Avian Influenza A Viruses in Domestic Ducks

Abstract

Waterfowl represent the natural reservoir of all subtypes of influenza A viruses, including H5N1. Ducks are especially considered major contributors to the spread of H5N1 influenza A viruses because they exhibit diversity in morbidity and mortality. Therefore, as a preventive strategy against endemic as well as pandemic influenza, it is important to reduce the spread of H5N1 influenza A viruses in duck populations. Here, we describe the pathogenicity of dominant clades (clades 1 and 2) of H5N1 influenza A viruses circulating in birds in Asia. Four representatives of dominant clades of the viruses cause symptomatic infection but lead to different profiles of lethality in domestic ducks. We also demonstrate the efficacy, cross-protectiveness, and immunogenicity of three different inactivated oil emulsion whole-virus H5 influenza vaccines (derived by implementing reverse genetics) to the viruses in domestic ducks. A single dose of the vaccines containing 1 mug of hemagglutinin protein provides complete protection against a lethal A/Duck/Laos/25/06 (H5N1) influenza virus challenge, with no evidence of morbidity, mortality, or shedding of the challenge virus. Moreover, two of the three vaccines achieved complete cross-clade or cross-subclade protection against the heterologous avian influenza virus challenge. Interestingly, the vaccines induce low or undetectable titers of hemagglutination inhibition (HI), cross-HI, and/or virus neutralization antibodies. The mechanism of complete protection in the absence of detectable antibody responses remains an open question.

Citing Articles

Multivalent Inactivated Vaccine Protects Chickens from Distinct Clades of Highly Pathogenic Avian Influenza Subtypes H5N1 and H5N8.

Kilany W, Safwat M, Zain El-Abideen M, Hisham I, Moussa Y, Ali A Vaccines (Basel). 2025; 13(2).

PMID: 40006750 PMC: 11860572. DOI: 10.3390/vaccines13020204.


Recombinant duck enteritis virus bearing the hemagglutinin genes of H5 and H7 influenza viruses is an ideal multivalent live vaccine in ducks.

Zhao Y, Chen P, Hu Y, Liu J, Jiang Y, Zeng X Emerg Microbes Infect. 2023; 13(1):2284301.

PMID: 37966272 PMC: 10769552. DOI: 10.1080/22221751.2023.2284301.


Avian Influenza NS1 Proteins Inhibit Human, but Not Duck, RIG-I Ubiquitination and Interferon Signaling.

Evseev D, Miranzo-Navarro D, Fleming-Canepa X, Webster R, Magor K J Virol. 2022; 96(18):e0077622.

PMID: 36069546 PMC: 9517716. DOI: 10.1128/jvi.00776-22.


Vaccine-Associated Enhanced Viral Disease: Implications for Viral Vaccine Development.

Halstead S BioDrugs. 2021; 35(5):505-515.

PMID: 34499320 PMC: 8427162. DOI: 10.1007/s40259-021-00495-6.


Vaccine Efficacy on the Novel Reassortant H9N2 Virus in Indonesia.

Dharmayanti N, Indriani R, Nurjanah D Vaccines (Basel). 2020; 8(3).

PMID: 32785201 PMC: 7565121. DOI: 10.3390/vaccines8030449.


References
1.
Peiris J, Yu W, Leung C, Cheung C, Ng W, Nicholls J . Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004; 363(9409):617-9. PMC: 7112424. DOI: 10.1016/S0140-6736(04)15595-5. View

2.
Swayne D, Beck J, Perdue M, Beard C . Efficacy of vaccines in chickens against highly pathogenic Hong Kong H5N1 avian influenza. Avian Dis. 2001; 45(2):355-65. View

3.
Perkins L, Swayne D . Pathogenicity of a Hong Kong-origin H5N1 highly pathogenic avian influenza virus for emus, geese, ducks, and pigeons. Avian Dis. 2002; 46(1):53-63. DOI: 10.1637/0005-2086(2002)046[0053:POAHKO]2.0.CO;2. View

4.
Scholtissek C, Burger H, Bachmann P, Hannoun C . Genetic relatedness of hemagglutinins of the H1 subtype of influenza A viruses isolated from swine and birds. Virology. 1983; 129(2):521-3. DOI: 10.1016/0042-6822(83)90194-0. View

5.
Kaverin N, Rudneva I, Govorkova E, Timofeeva T, Shilov A, Kochergin-Nikitsky K . Epitope mapping of the hemagglutinin molecule of a highly pathogenic H5N1 influenza virus by using monoclonal antibodies. J Virol. 2007; 81(23):12911-7. PMC: 2169086. DOI: 10.1128/JVI.01522-07. View